Facial cellulitis: an early indicator of group B streptococcal bacteremia.
Epithelial manifestations as indicators of group B streptococcal (GBS) bacteremia have been infrequently reported in the literature. This report describes three infants, ranging in age from 2 1/2 weeks to 7 weeks, who were seen with facial cellulitis as the only sign of GBS bacteremia. Only one of these infants had fever on presentation; otherwise, there were no signs of systemic illness. "Spontaneous cellulitis" should be viewed as an indicator of underlying bacteremia; in an infant less than 3 months of age, GBS should be considered a prime etiologic agent.
D000667:Ampicillin / Q000627:therapeutic use; D002481:Cellulitis / Q000175:diagnosis* / Q000188:drug therapy; D005148:Facial Dermatoses / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis* / Q000188:drug therapy; D007235:Infant, Premature, Diseases / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D010400:Penicillin G / Q000627:therapeutic use; D013290:Streptococcal Infections / Q000097:blood*; D013292:Streptococcus agalactiae / Q000302:isolation & purification
D000667:Ampicillin; D010400:Penicillin G